Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Not Applicable
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Behavioral: Balance training program
- Registration Number
- NCT01424098
- Lead Sponsor
- Roger Goldstein
- Brief Summary
A growing body of evidence suggests that individuals with chronic lung disease have important deficits in balance control that may be associated with an increased risk of falls. The main purpose of this study is to examine the effects of a balance training program on measures of balance and fall risk in people with chronic lung disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
- Diagnosis of COPD; a self-report of decline in balance or fall in the last 5 years or a recent near fall; smoking history greater than 10 pack years; and are able to provide written informed consent.
Exclusion Criteria
- Inability to communicate because of language skills, hearing or cognitive impairment; and evidence of a neurological or musculoskeletal condition that severely limits mobility and postural control (e.g., cerebrovascular accident, advanced Parkinson's disease, amputation).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Balance Training Balance training program The treatment group will complete a specific balance training program in addition to conventional pulmonary rehabilitation.
- Primary Outcome Measures
Name Time Method Berg Balance Scale All outcomes will be assessed upon admission to pulmonary rehabilitation (baseline) and again upon completion of the program, an expected average of 6 weeks from baseline. Balance Evaluation Systems Test At baseline and 6 weeks.
- Secondary Outcome Measures
Name Time Method Self-reported physical function At baseline and 6 weeks. Functional strength At baseline and 6 weeks. Balance confidence/falls self-efficacy At baseline and 6 weeks.
Trial Locations
- Locations (1)
West Park Healthcare Centre
🇨🇦Toronto, Ontario, Canada